1. teckback
2. jcacrmn
3. hgresser
4. bigwhit244
1.jcacrmn 01/25/2018
Great news today! - Cantor Fitzgerald reiterates Buy rating, $10 PT
2.hgresser 02/06/2018
Where Is Synergy Pharmaceuticals Inc Heading From Here? H.C. Wainwright Weighs In - Smarter Analyst
3.teckback 01/09/2018
Synergy Pharmaceuticals Inc (SGYP) Savvy Leadership Turnover and Upcoming Trulance Approval in IBS-C Have This Bull Confident
4.jcacrmn 02/01/2018
Big news out... - H.C. Wainwright & Co. reiterates Buy rating, $7 PT
5.hgresser 01/25/2018
Synergy Pharmaceuticals Inc Enters a Fiercely Competitive IBS-C Market, But
6.teckback 01/25/2018
Company update
7.bigwhit244 01/22/2018
Analyst Questions Whether Label Expansion for Trulance Will Prove to Be a driver
8.teckback 02/28/2018
Acquires exclusive Canadian rights to FDA-Approved Trulance from Synergy Pharmaceuticals
9.teckback 01/25/2018
Announces FDA approval of TRULANCE (Plecanatide) for the treatment of irritable bowel syndrome with constipa…
10.teckback 01/09/2018
Hmmmm: - Dilution Fears Continue to Hit Synergy Pharmaceuticals Inc (SGYP); Oppenheimer Downgrades the Stock
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW